Showing results (1151-1160 of 1,535) with videos related to
Sort By:
Pageof 154
Cancer Management and Research|December 18, 2018
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapyDenise Bernhardt, Sophie Aufderstrasse, Laila König, et al.Histopathology|July 8, 2020
Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA-binding protein 3 in non-small-cell lung cancerKatharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, et al.Chemmedchem|August 28, 2020
Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine ReceptorManuela Jörg, Elham Khajehali, Emma T van der Westhuizen, et al.Plos One|August 12, 2016
Disparities in Depressive Symptoms and Antidepressant Treatment by Gender and Race/Ethnicity among People Living with HIV in the United StatesAngela M Bengtson, Brian W Pence, Heidi M Crane, et al.ACS Chemical Neuroscience|July 18, 2025
A Structure-Activity Relationship Study of Novel Positive Allosteric Modulators for the δ-Opioid ReceptorOwindeep Deo, Vi Pham, Sadia Alvi, et al.JTO Clinical and Research Reports|July 26, 2022
Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Sta ge NSCLC With High Programmed Death-Ligand 1 Express ionTimothy Rajakumar, Rastislav Horos, Paul Kittner, et al.Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophreniaW Y Chan, D L McKinzie, S Bose, et al.Molecular Pharmacology|September 30, 2016
Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and CooperativityAnh T N Nguyen, Elizabeth A Vecchio, Trayder Thomas, et al.Molecular Pharmacology|December 25, 2015
A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism: Lessons from Class B Crystal StructuresDenise Wootten, Christopher A Reynolds, Cassandra Koole, et al.Translational Lung Cancer Research|December 13, 2023
Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case reportBowen Li, Ziqi Jia, Zhicheng Huang, et al.Pageof 154